Drug Discovery & Development
In vivo models
Combination therapy with anti-PD1 or anti-CTLA4
This type of therapy allows the targeting of mechanisms or pathways that have an important role in the development of cancers. In vivo tests provide a means of evaluating the effectiveness of these PD1 or CTLA4 therapies. Tumor cells are injected subcutaneously. When the size of the tumor is reached, antibody injections and tumour progression allow the effectiveness of the treatment to be monitored.
Further details on the project may be requested directly by the expert. You will be able to exchange directly with the experts after filling in the form below.
Please answer all questions below to specify your requirements
Please answer all questions. If you are not logged in, you will be redirected.